Recordati Competitors and Similar CompaniesClear all

Recordati's competitors and similar companies include Agios Pharmaceuticals, Pharmstandard and Debiopharm.

	Recordati Recordati Industria Chimica e Farmaceutica is a company that specializes in the manufacturing and marketing of pharmaceutical products.	Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.	Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.	Debiopharm Debiopharm is a biopharmaceutical company specializing in oncology and bacterial infections.
Founding Date	Founding Date 1926	Founding Date 2008	Founding Date 2003	Founding Date 1979
Type	Type Public	Type Public	Type Subsidiary	Type Private
Tags	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma	Tags Healthcare drug development oncology pharma
Locations	Locations Milano, IT HQ Campoverde, IT	Locations Cambridge, US HQ	Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Tomsk, RU Ufa, RU	Locations Lausanne, CH HQ Oss, NL
Employees	Employees 4,450	Employees 53611% increase	Employees 1,15526% decrease	Employees 502
Valuation ($)	Valuation ($) 12 b	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) €2.1b (FY, 2023)	Revenue (est.) $26.8m (FY, 2023)	Revenue (est.) ₽142.9b (FY, 2023)	Revenue (est.) N/A
Cost of goods	Cost of goods €459.3m (FY, 2023)	Cost of goods $2.9m (FY, 2023)	Cost of goods ₽109.3b (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit €1.6b (FY, 2023)	Gross profit $23.9m (FY, 2023)	Gross profit ₽33.6b (FY, 2023)	Gross profit N/A
Net income	Net income €389.2m (FY, 2023)	Net income ($352.1m) (FY, 2023)	Net income ₽23.3b (FY, 2023)	Net income N/A